Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

July 11, 2020

Evaluating interventions to delay the progression of prediabetes to type-2 diabetes mellitus in an uninsured Hispanic population

Journal of the American Association of Nurse Practitioners
Ophelia Botah-Oduro, Michele H Talley
July 11, 2020

Blood-glucose control in eldely patients with type 2 diabetes. Interventions to avoid risks

M J Hernández ArroyoM Rodríguez Benito
July 11, 2020

Blood pressure control in type 2 diabetes mellitus with arterial hypertension. The important ancillary role of sglt2-inhibitors and glp1-receptor agonists

Pharmacological Research : the Official Journal of the Italian Pharmacological Society
C BerraF Folli
July 9, 2020

Low-carbohydrate diets and type 2 diabetes treatment: a meta-analysis of randomized controlled trials

Acta Diabetologica
G A SilveriiE Mannucci
July 9, 2020

Non-invasive risk scores do not reliably identify future cirrhosis or hepatocellular carcinoma in Type 2 diabetes: The Edinburgh Type 2 Diabetes Study

Liver International : Official Journal of the International Association for the Study of the Liver
Sheila M GrecianMark Wj Strachan
July 8, 2020
Open Access

Health Insurance Is Associated with Decreased Odds for Undiagnosed Prediabetes and Type 2 Diabetes in American Adults

International Journal of Environmental Research and Public Health
Sean MahoneyRyan McGrath
July 9, 2020

Evaluating the Impact of Mobile Phone Technology on Health Outcomes for Latinos with Type 2 Diabetes

Journal of Racial and Ethnic Health Disparities
Laura V JacksonRalph A Herrera
July 10, 2020
Open Access

Clinical inertia in patients with type 2 diabetes treated with oral antidiabetic drugs: results from a Japanese cohort study (JDDM53)

Journal of Diabetes Investigation
Hiroshi MaegawaJapan Diabetes Clinical Data Management (JDDM) Study Group

Sign up to follow this feed and discover related papers.

Related Feeds

Aging & Diabetes

This feed focuses on the role of the aging process on developing diabetes.

Antidiabetic Cellular Plasticity

This feed focuses on mechanisms that underlie cellular plasticity as a treatment for diabetes and other degenerative diseases.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.


Asprosin is a fasting-induced hormone produced in the white adipose tissue to stimulate the hepatic release of glucose into the bloodstream. Discover the latest research on this protein hormone here.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Autophagy & Metabolism

Autophagy preserves the health of cells and tissues by replacing outdated and damaged cellular components with fresh ones. In starvation, it provides an internal source of nutrients for energy generation and, thus, survival. A powerful promoter of metabolic homeostasis at both the cellular and whole-animal level, autophagy prevents degenerative diseases. It does have a downside, however--cancer cells exploit it to survive in nutrient-poor tumors.

Biomarkers for Diabetes

This feed focuses on the latest research on biomarkers used for monitoring disease progression in diabetes.

COVID-19 & Diabetes (ADA)

COVID-19 (short for “Coronavirus Disease 2019") is the disease caused by the novel coronavirus, SARS-CoV-2. Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. COVID-19 represents a particular challenge to people with serious chronic medical conditions such as diabetes. To keep our community as informed as possible, the American Diabetes Association is partnering with the Chan Zuckerberg Initiative's Meta to highlight the latest research developments at the intersection of COVID-19 and diabetes.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

© 2020 Meta ULC. All rights reserved